We describe the isolation, lipid-binding properties and partial amino acid sequence of PS-p68, a novel 68 kDa phosphatidylserine-binding protein from human platelets. PS-p68 is an abundant constituent of platelets, accounting for 0.5-0.75 % of total cell protein. It was purified from platelet cytosol by affinity chromatography. Amino acid sequence analysis yielded no similarity to identified proteins. In contrast with most known phospholipid-binding proteins, PS-p68 does not bind Ca2' and does not require Ca2+ for its binding of phosphatidylserine. Phosphatidylserine binding to PS-p68 was inhibited by phosphatidic acid and by alkylphospholipids. PS-p68 was isolated as a major phosphoprotein from 32p_ labelled platelets and was found to function as a protein kinase C substrate in vitro. However, treatment of intact platelets with phorbol 12-myristate 13-acetate, thrombin or carbacyclin did not increase PS-p68 phosphorylation. Platelets appear to be the only blood cells containing PS-p68, which was not detected in neutrophils, monocytes and lymphocytes.
INTRODUCTION
In the accompanying paper we describe a novel class of proteins that bind phosphatidylserine (PS). These proteins bind phospholipids in the absence of Ca2+ and also bind protein kinase C in the presence of PS [1] . PS-binding proteins of molecular masses 115 kDa and 100 kDa were found in neutrophils, monocytes, lymphocytes, platelets and erythrocytes. In platelets, however, the principal PS-binding species is a cytosolic protein of molecular mass 68 kDa. In the present paper we describe the purification, partial amino acid sequence and properties of this novel PS-binding protein, termed PS-p68.
MATERIALS AND METHODS Cells
Platelets, neutrophils, monocytes and lymphocytes were isolated from buffy coats of citrate-anticoagulated donor blood (Swiss Red Cross Laboratory, Bern, Switzerland) as described in the accompanying paper [1] .
Purification of PS-p68
Cytosol from 100 ml of platelets (7.5 x I09 cells/ml) was prepared by sonication (Branson Sonic Power, 4°C for 2 min) in a buffer containing 20 mM-Hepes, 138 mM-NaCl, 3.3 mM-KCl, 1 mM-MgCl2, 5 mM-EGTA, 1 mM-phenylmethanesulphonyl fluoride and 0.045 mM-leupeptin, pH 7.3, followed by ultracentrifugation (150000 g for 30 min). Cytosolic proteins were fractionated by (NH4)2SO4 precipitation. The precipitate obtained at 20-40 % saturation was resuspended in 27 ml of a buffer containing 20 mM-Tris/HCI, 150 mM-NaCI, 4 M-urea, I mM-EDTA and 1 mM-EGTA, pH 7.7, and 6.2 ml portions were loaded on a 100 cm x 2 cm Ultrogel AcA-34 column (IBF Biotechnics, Villeneuve-la-Garenne, France). After SDS/PAGE and transfer to nitrocellulose, the fractions containing PS-p68 were identified by overlay with [14C]PS or with anti-PS-p68 serum. Active fractions were pooled and chromatographed on a 12 cm x 1.6 cm Q-Sepharose column (Pharmacia, Uppsala, Sweden) with a gradient of0.15-1.0 M-NaCl in a buffer containing 10 mM-Tris/HCl, 4 M-urea and 0.1 mM-EDTA, pH 7.7. PS-p69-containing fractions were again pooled, freed of urea by dialysis against buffer A (20 mM-Tris/HCI containing 200 mM-NaCl, pH 7.7) and loaded on to a PS-Sepharose affinity column. The column was then washed with 5 column volumes of buffer A, and PS-p68 was eluted with 3 M-urea in buffer A. The PS-Sepharose affinity column was prepared by coupling of PS vesicles to CNBr-activated Sepharose [2] . Briefly, 15 mg of phosphatidylserine (PS), 7.5 mg of phosphatidylethanolamine and 7.5 mg of phosphatidylcholine (PC) were mixed and dried under N2. The mixture was sonicated in ice for O min in 30 ml of 0.1 MNaHCO3 containing 0.5 M-NaCl, pH 8.0, and then allowed to couple to CNBr-activated Sepharose at room temperature for 1 h. After blocking for 1 h with 0.1 M-Tris/HCI containing 0.5 MNaCl, pH 8.0, a column was prepared (1-15 ml gel volume), washed three times with alternating 0.1 M-sodium acetate containing 0.5 M-NaCl, pH 5.0, and 0.1 M-Tris/HCl containing 0.5 M-NaCI, pH 8 Phosphorylation of platelets A 10-20 ml portion of citrate-anticoagulated platelet-rich plasma was adjusted to pH 6.5 with 1 M-HCI. Apyrase (0.07 unit/ml; Sigma Chemical Co., St. Louis, MO, U.S.A.) and Iloprost (1 ng/ml; Schering A.G., Berlin, Germany) were added, and the volume was adjusted to 50 ml with washing buffer (containing 4.3 mM-K2HPO4, 4.3 mM-Na2HPO4, 24.4 mmNaH2PO4, 113 mM-NaCl and 5.5 mM-glucose, pH 6.5). After centrifugation at 1200 g for 10 min, the sedimented platelets were resuspended at 109 cells/ml in a buffer containing 20 mM-Hepes, 140 mM-NaCl, 5.5 mM-glucose and 0.035 unit of apyrase/ml, pH 7.5. To allow relaxation [10] , the cells were incubated at 37°C for 1 h. [32P]P1 (1 mCi/ml) was added and the cells were labelled at 37°C for 1 h, and the cells were then layered on a 15 % (w/v) sucrose cushion (1 ml of cells/ml of sucrose) and centrifuged at 14500 g for 3 min to remove free [32P]Pi. The platelets were resuspended in the same buffer and incubated at 37°C for 15-30 min, before exposure to the stimuli. Stimulation was terminated by freezing the samples in liquid N2 after addition of proteinase inhibitors (2 mM-EDTA, 0.045 mM-leupeptin and 1 mM-phenylmethanesulphonyl fluoride) and, in some experiments, phosphatase inhibitors (0.1 mM-sodium orthovanadate and 10 mM-sodium pyrophosphate). After thawing, the platelets were lysed by sonication and centrifuged at 225 000 g for 10 min at 4°C (Beckman TL-100 ultracentrifuge). The supernatant was applied to the PS-Sepharose affinity column (1 x 101 platelets/ 200 ,ul of gel). After a washing with 3 ml of buffer A, PS-p68 was eluted with 3 M-urea. Proteins in the wash and eluate fractions were precipitated with 100% (w/v) trichloroacetic acid and analysed by SDS/PAGE. Alternatively, PS-p68 obtained from the affinity column was further purified by SDS/PAGE on an 8 %/ polyacrylamide gel and blotting on to Immobilon membrane. Each band of the doublet migrating at 68 kDa was cut out and subjected to phospho amino acid analysis separately.
Alternatively, stimulation was terminated by adding I %/_ SDS, and phosphoproteins were analysed by two-dimensional electrophoresis [11] followed by immunoblotting and autoradiography. 
Anti-PS-p68 serum
Antiserum to PS-p68 was generated by subcutaneous immunization of rabbits with 30 ,ug of purified protein in complete (first injection) or incomplete Freund's adjuvant (three additional injections). Affinity-purified antibody was prepared as described by Olmsted [14] .
Protein quantification Protein concentration was determined by the bicinchoninic acid method (BCA; Pierce Chemical Co., Rockford, IL, U.S.A.) in 96-well micro-titre plates according to the manufacturer's instructions.
RESULTS

Purification of PS-p68
The PS-binding protein of PS-p68 from human platelet cytosol was purified in a four-step procedure. In early experiments the purification of PS-p68 was monitored by [14C]PS binding, and in later experiments by immunoblotting with anti-PS-p68 serum. The material precipitated from the cytosol by (NH4)2SO4 (20-40 % saturation) was chromatographed on an Ultrogel AcA-34 column. Active fractions were pooled and applied to a QSepharose column, from which PS-p68 was eluted at about 0.26 M-NaCl. The final step of purification consisted of a phospholipid-Sepharose affinity column, from which PS-p68 was eluted with 3 M-urea.
On an SDS/PAGE gel PS-p68 could be identified as a closely spaced doublet migrating with a molecular mass of about 68 kDa (Fig. la) . The relative amounts of the two components of the doublet varied, but in general the lower band was more prominent on Coomassie Blue staining. The PS-p68 doublet was the only platelet cytosol protein reacting on an immunoblot with the affinity-purified antibody directed against PS-p68 (Fig. lb) . Fig.  I(c (Fig. 2) . To assess whether any PS-p68 is associated with the cytoskeleton, platelets were lysed with 1 % Triton X-l100 and the cytoskeleton was isolated as the insoluble fraction after centrifugation at 14000 g for 5 min. The immunoblot in Fig. 2 shows that PS-p68 is not. associated with the cytoskeleton. Fig. 3(a) shows a Coomassie Blue stain of the fragments, from which the molecular masses, indicated in Table 1, were derived. An overlay with ['4CJPS showed that the PS-binding site is localized in fragment D (22 kDa). Furthermore, PS-p68 was found to be a protein kinase C substrate (see also Fig. 6c ) and-the phosphorylation site is also localized in fragment D (Figs. 3b and Vol. 269 4a ). CaCI2 and MgCl2 were not required for binding and were inhibitory at 5 mm. PS binding was also inhibited by two negatively charged phospholipids, phosphatidic acid and phosphatidylinositol, and by the alkylphospholipids plateletactivating factor, lyso-platelet-activating factor and 1-0-hexadecyl-2-0-methylglycerol. Protein kinase C added during or after incubation with PS bound to the complex of PS and PS-p68 by a mechanism similar to that described in the accompanying paper for PS-p15/100 [1] .
To obtain assurance that PS-p68 also binds to phospholipids under physiological conditions, the native protein was incubated with PS vesicles or PC vesicles in a buffer that mimics intracellular ionic concentrations. As shown in Fig. 4(b) , PS-p68 associated with PS vesicles but not PC vesicles in a Ca2+-independent manner.
The conditions for the binding of PS-p68 to phospholipids were further studied by using PS-Sepharose affinity chromatography. Cytosol of 32P-labelled platelets was supplemented with 3 mM-CaCl2 and loaded on to the PS-Sepharose affinity column, which was then eluted with a buffer containing 2 mM-EDTA. Fig. 5 (lane 3) demonstrates that a number of proteins, but no PS-p68, could be released from the column under Ca2+-chelating conditions. Elution of PS-p68 required addition of 3 M-urea to the buffer (Fig. 5, lane 4) . The autoradiogram in Fig. 5(b affinity column and eluted with 3 M-urea. The autoradiogram in Fig. 6(a) shows that PS-p68 exists as a phosphoprotein in intact platelets. Only minor changes in the degree of phosphorylation were observed upon exposure of the platelets to thrombin, carbacyclin or phorbol 12-myristate 13-acetate, the apparent decrease following stimulation with thrombin being due to a consistent decrease in the PS-p68 yield under these conditions. On the other hand, thrombin and phorbol 12-myristate 13-acetate induced a marked increase of 32P incorporation into p47, the major protein kinase C substrate in platelets (results not shown). The degree of phosphorylation of PS-p68 was not affected by the addition of phosphatase inhibitors (10 mM-sodium pyrophosphate and 0.1 mM-sodium orthovanadate) before freezing the cells. Two-dimensional SDS/PAGE of 32P-labelled platelets showed that PS-p68, which was identified as a doublet by immunoblotting, is a major phosphoprotein (Fig. 6b) . In a cell-free assay, PS-p68 was readily phosphorylated by protein kinase C (Fig. 6c) . Phospho amino acid analysis revealed that both components of the p68 doublet were phosphate-labelled on serine residues when PS-p68 was phosphorylated in intact platelets or by protein kinase C after purification (results not shown).
Distribution of PS-p68 in blood cells
Using an affinity-purified antibody to PS-p68, we examined neutrophils, monocytes, lymphocytes, erythrocytes (results not shown), blood plasma and the leukaemic cell line HL-60 for this protein. Western blotting after SDS/PAGE of cell lysates demonstrates that PS-p68 is unique for platelets, since none of the other cells showed immunoreactivity (Fig. 7) . The lysate of HL-60 cells, however, revealed an immunoreactive band of somewhat larger size than PS-p68.
DISCUSSION
We purified and partially characterized PS-p68, a novel phospholipid-binding protein (PBP) that is an abundant constituent of human platelet cytosol. PBPs have been implicated in a wide range of cellular functions (as reviewed in ref. [15] ), including exocytosis (synexin and calelectrin), interactions of cytoskeletal elements with plasma membrane (calpactins, endonexin and calelectrin) and modulation of membraneassociated enzymes or receptors (calpactins). At least six distinct PBPs belong to the annexin family of proteins, which share a common repeated subunit structure [16, 17] . Within Vol. 269 (a) Most PBPs have affinity for negatively charged phospholipids without strict selectivity for single phospholipid head-groups [15] . The binding of PS-p68 to phosphatidic acid and plateletactivating factor therefore does not necessarily imply a lipidregulatory role for this protein. In view of the antagonistic effects of platelet-activating factor and the possible involvement of phosphatidic acid in signal transduction, further studies are needed to explore the role of PS-p68 in platelet function. Such studies may also help to explain why a protein that binds so strongly to PS is recovered in the cytosol rather than in association with membranes.
The interaction of known PBPs with phospholipids requires Ca2+ in the micromolar range or greater [15, 18] , and many of these proteins have been shown to bind Ca2+ with an affinity that is approximately in the same range. Although PS-p68 resembles other PBPs in its ability to bind phospholipids, it does not bind Ca2+ or require micromolar Ca2+ for its PS-binding activity. Thus the Ca2+ requirement of PBPs described to date may not be an essential feature of these proteins.
Certain PBPs are tyrosine kinase substrates [15] (calpactin I is a substrate of pp6o rC, calpactin II is a substrate of the epidermalgrowth-factor receptor). Unlike calpactins, PS-p68 is phosphorylated exclusively on serine residues and is not recognized by anti-phosphotyrosine antibodies. Although in these preliminary experiments we did not observe stimulusdependent changes in PS-p68 phosphorylation, more detailed time-course studies with a wider range of stimuli will be necessary to determine how the phosphorylation of PS-p68 is controlled. Many proteins are phosphorylated in resting platelets [19] , and PS-p68, which was identified as a major phosphoprotein on twodimensional PAGE, could belong to this category. PS-p68 most probably corresponds to the cytosolic phosphoprotein termed p80 in a study of hydrophilic and hydrophobic platelet proteins using Triton X-1 14 phase separation [11] . The role of phosphorylation and dephosphorylation has not been clarified so far. In vitro, PS-p68 was readily phosphorylated by protein kinase C, but incorporation of 32p was not increased in platelets that were stimulated with phorbol 12-myristate 13-acetate, suggesting that PS-p68 may not be accessible to protein kinase C in intact cells either through masking or binding by other proteins.
The properties of PS-p68 differ from those of other PBPs reported to date, and the available sequence data (70 of the estimated total of 570 amino acid residues) establish that PS-p68 is distinct from known and completely sequenced proteins. The role of this and other PBPs in cellular function requires further investigation.
